Laurus Labs Cash Flow Annual

BSE: 540222 | NSE: LAURUSLABS | ISIN: INE947Q01028 | Sector: Biotechnology & Drugs

1,807.00 -7.40 (-0.41%)Updated : 19 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	-330.08	156.14	507.76	213.79
Net Changein Cash	13.12	-39.40	93.27	-29.68
Cash Taxes Paid	293.86	137.54	104.57	285.49
Net Income/ Starting Line	1,181.88	484.29	236.36	1,108.94
Total Cash Dividends Paid	-86.33	-43.13	-86.18	-107.47
Changesin Working Capital	-268.78	-512.14	-133.59	-600.75
Cashfrom Operating Activities	1,623.50	601.65	665.69	993.90
Cash Interest Paid	170.69	209.22	174.31	140.40
Cashfrom Financing Activities	-524.72	39.28	249.83	-26.64
Issuance( Retirement)of Stock Net	20.00	10.17	2.56	7.44
Depreciation/ Depletion	480.05	430.09	384.58	324.08
Other Investing Cash Flow Items Total	-18.71	-40.72	-144.11	-5.90
Capital Expenditures	-1,069.95	-641.00	-678.31	-990.16
period Type	-	-	-	-
Foreign Exchange Effects	3.00	1.39	0.17	-0.88
Non- Cash Items	230.35	199.41	178.34	161.63
Financing Cash Flow Items	-128.31	-83.90	-174.31	-140.40
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-1,088.66	-681.72	-822.42	-996.06

*All figures in crores except per share values

Trending Stocks

1,322.50+22.50(1.73%)

320.20+4.20(1.33%)

392.05+4.75(1.23%)

262.45-5.35 (-2.00%)

1,078.60-14.35 (-1.31%)

Related News